These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9062556)

  • 1. The anti-HIV-1 activity associated with saliva.
    Shine N; Konopka K; Düzgüneş N
    J Dent Res; 1997 Feb; 76(2):634-40. PubMed ID: 9062556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous mucosal antiviral factors of the oral cavity.
    Shugars DC
    J Infect Dis; 1999 May; 179 Suppl 3():S431-5. PubMed ID: 10099113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
    Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
    J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral transmission of HIV, reality or fiction? An update.
    Campo J; Perea MA; del Romero J; Cano J; Hernando V; Bascones A
    Oral Dis; 2006 May; 12(3):219-28. PubMed ID: 16700731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the oral environment in HIV-1 transmission.
    Shugars DC; Wahl SM
    J Am Dent Assoc; 1998 Jul; 129(7):851-8. PubMed ID: 9685760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.
    Kazmi SH; Naglik JR; Sweet SP; Evans RW; O'Shea S; Banatvala JE; Challacombe SJ
    Clin Vaccine Immunol; 2006 Oct; 13(10):1111-8. PubMed ID: 16928883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of HIV infection on oral mucosal immunity.
    Challacombe SJ; Naglik JR
    Adv Dent Res; 2006 Apr; 19(1):29-35. PubMed ID: 16672546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals.
    Spear GT; Alves ME; Cohen MH; Bremer J; Landay AL
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):129-36. PubMed ID: 16051064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (C2) Saliva, breast milk, and mucosal fluids in HIV transmission.
    Page-Shafer K; Sweet S; Kassaye S; Ssali C
    Adv Dent Res; 2006 Apr; 19(1):152-7. PubMed ID: 16672566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva and salivary gland alterations in HIV infection: a review.
    Matee MI; Simon E
    Afr Dent J; 1995; 9():25-9. PubMed ID: 9590897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral HIV-exposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men.
    Hasselrot K; Säberg P; Hirbod T; Söderlund J; Ehnlund M; Bratt G; Sandström E; Broliden K
    AIDS; 2009 Jan; 23(3):329-33. PubMed ID: 19114861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral HIV transmission.
    Younai FS
    J Calif Dent Assoc; 2001 Feb; 29(2):142-8. PubMed ID: 11324114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of human herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients.
    Triantos D; Horefti E; Paximadi E; Kyriakopoulou Z; Karakassiliotis G; Papanastasiou K; Lelekis M; Panos G; Donta-Bakoyianni C; Rapidis A; Markoulatos P
    Oral Microbiol Immunol; 2004 Jun; 19(3):201-4. PubMed ID: 15107073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 exposed uninfected men who have sex with men have increased levels of salivary CC-chemokines associated with sexual behavior.
    Hasselrot K; Bratt G; Duvefelt K; Hirbod T; Sandström E; Broliden K
    AIDS; 2010 Jun; 24(10):1569-75. PubMed ID: 20549845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage.
    Sun D; Archibald DW; Furth PA
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):933-41. PubMed ID: 2117957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mucosal immunity and HIV/SIV infection.
    Lü FX; Jacobson RS
    J Dent Res; 2007 Mar; 86(3):216-26. PubMed ID: 17314252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.
    Baqui AA; Meiller TF; Falkler WA
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):808-11. PubMed ID: 10548568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons.
    Qureshi MN; Barr CE; Seshamma T; Reidy J; Pomerantz RJ; Bagasra O
    J Infect Dis; 1995 Jan; 171(1):190-3. PubMed ID: 7798662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV topic update: oro-genital transmission of HIV.
    Scully C; Porter S
    Oral Dis; 2000 Mar; 6(2):92-8. PubMed ID: 10702785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.